Harvard Medical School Publication to Improve Health and Quality of Life for Men with Prostate Disease.
BOSTON, Feb. 5 /PRNewswire-USNewswire/ -- Harvard Health Publications, the publishing division of Harvard Medical School, has released the premier issue of a quarterly publication entitled "Harvard Medical School Perspectives on Prostate Disease." The publication is created to help men understand the options available to them, so they can make...

Herbal help for prostate health: September's Prostate Cancer Awareness Month has passed, but it's no reason to slack on maintaining health, especially when you can turn to herbs.
Prostate health and the prevention of prostate disease should be a health concern of all men. After all, prostatitis, an acute or chronic inflammation of the prostate, affects 35 percent of men over 50. More than 50 percent of men over the age of 60 have symptoms of prostate...

ProUroCare Inks Licensing and Development Pact with Artann Laboratories.
HEALTH AND BEAUTY CLOSE-UP-3 August 2008-ProUroCare Inks Licensing and Development Pact with Artann Laboratories(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com ProUroCare Medical announced that it has entered into two agreements with Artann Laboratories of Trenton, New Jersey (Artann) to complete development, conduct clinical trials and file for FDA regulatory...

Lipid levels, prostate disease linked.
BOSTON -- Among men with prostate cancer, those with low plasma cholesterol are significantly less likely to develop more aggressive forms of the disease, compared with those who have higher cholesterol levels, Elizabeth A. Platz, Sc.D., reported at the annual international conference of the American Association for Cancer Research....

Telemedicus Names New COO.
HEALTH AND BEAUTY CLOSE-UP-13 February 2008-Telemedicus Names New COO(C)2008 - CloseUpMedia - newsdesk@closeupmedia.com Telemedicus announced that it has appointed marketing president, Steve Price, as new Chief Operating Officer. Price will be responsible for the product launch of the Digital EMS DREAMS platforms. Steve...

Urologix names co-founder as chairman and CEO.
The board of Urologix, Inc., a Minneapolis, MN-based manufacturer of products used to treat urological disorders, has named Mitchell Dann as its new chairman and interim CEO. The move comes after Fred B. Parks, the company's former chairman and CEO, resigned. The company offered no reason for...

Section V: biomedical sciences.
PROSTATE CANCER AND CONSTITUTIVE EXPRESSION OF IMMUNOSUP PRESSIVE CYTOKINES AND CHEMOKINES, Godwin A. Ananaba* (1), K. Gordon (1), G. Ifere A. Campbell (1), E. Ekong (2), F.O. Eko (2) and J. Igietseme (3), Clark Atlanta University, Atlanta, GA 30314, Morehouse School of Medicine and Centers for Disease Control &...

Life-saving advances in prostate cancer testing.
[ILLUSTRATION OMITTED] Prostate cancer is one of the most insidious threats facing aging men today. This devastating disease is now the second leading cause of cancer death among American men after lung cancer. [ILLUSTRATION OMITTED] Perhaps the greatest breakthrough in the detection and...

Advances in prostate cancer chemoprevention and treatment.
[ILLUSTRATION OMITTED] Prostate cancer kills 31,000 men in the US each year. Over 220,000 are diagnosed with the disease each year--the equivalent of a new diagnosis every 2.6 minutes. A man's lifetime chance of developing this cancer is about one in six. At this writing, prostate cancer...

Prostate health: getting down to specifics: for years, researchers worked to discover a more specific prostate cancer marker--the hard work is finally paying off!
No one questions the pivotal role that the prostate specific antigen (PSA) test has played in saving lives. When the PSA was introduced, the Post heralded its arrival, later launching the MaleMobile in 1992 to offer free prostate exams to men 50 and older, helping raise awareness of the...